Pancreatic Neuroendocrine Tumors: The Basics, the Gray Zone, and the Target

F1000Research - United Kingdom
doi 10.12688/f1000research.10188.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd

Related search

Pancreatic Neuroendocrine Tumors

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2017English

State-Of-The-Art Imaging of Pancreatic Neuroendocrine Tumors

Surgical Oncology Clinics of North America
SurgeryOncology
2016English

The Risk of Recurrence in Grade 2 Pancreatic Neuroendocrine Tumors

HPB
HepatologyGastroenterology
2018English

Promising Developments for Pancreatic Neuroendocrine Tumors

Cancer Discovery
Oncology
2011English

Differences Between Grades G1 and G2 Hypovascular Pancreatic Neuroendocrine Tumors and Pancreatic Neuroendocrine Carcinoma

Radiology
Nuclear MedicineRadiologyImaging
2017English

Role of Sunitinib for the Management of Pancreatic Neuroendocrine Tumors

Gastrointestinal Cancer: Targets and Therapy
2011English

Risk Factors for Pancreatic Neuroendocrine Tumors

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2014English

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors

Cancers
Cancer ResearchOncology
2010English

The Diagnostic Value of FNA Biopsy in Grading Pancreatic Neuroendocrine Tumors

Cancer cytopathology
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy